Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 301–310 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 301
- Medicine slug
- ciprofloxacin
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 146
- Source count
- 119
- Agreement rate
- 0.966387
- Recorded readings
4 hours
- Numeric value
- 4
- Unit
- hours
- Source records
- 115
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 115 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e237dd23-faf3-1765-e053-2a95a90ae62d (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6971a958-08f0-4712-bf5f-47fe4f76b863 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbcd32c0-bcfd-4cc7-8e81-6612bc0cfc45 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17435f05-f04d-e792-e063-6294a90af145 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c355077-7361-41d0-9e82-eb31beaf5daa (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d17b0e87-b555-4dfb-e053-2a95a90aa5ef (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fd3da0b-7428-ac8f-e053-2a91aa0aed9f (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36d6c27d-45dc-3081-e063-6394a90a87e9 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5af16acc-51ce-41ed-b1c4-6b3fb38ef515 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fe3becb-f90e-4187-a8e8-bd0de5a79ad2 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c08b37c3-5f01-47ed-9508-02813bbd008b (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4dd69fb7-802a-4278-a730-c722a3ca3521 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f67d727f-b9ca-aec0-e053-2995a90aab69 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d88a22f4-2f61-17f2-e053-2995a90acd14 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f600112-168a-4a58-9914-7c01f71894da (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bb1d26e-fad0-4338-8948-3f095d5817a6 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ee1f252-a64e-4b72-a6f7-60298e827222 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:641729a3-6dd3-3a2f-e053-2991aa0a015e (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44e5582d-fff1-0ec9-e054-00144ff88e88 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d358eb18-f4d0-e9ba-e053-2a95a90a435d (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d23e359d-6d12-38f6-e053-2a95a90a0a88 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2efbda2a-fc97-b7c5-e063-6294a90a362d (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69df48cc-76b6-428e-891a-c25e07d785f8 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:acb03e72-ce94-58c5-e053-2a95a90a683a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d029ad2-a1e8-4c11-a5eb-e2257c6a0ddb (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4972e902-e042-e947-e063-6394a90a1b70 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2d8dcc9-23b0-75bb-e053-2995a90a02c8 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c32ccb5f-b9d7-0aff-e053-2995a90afe6d (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7ac7e18-fd34-44df-8a0e-87dafbc7a2f5 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a05035e1-f941-4f7c-9321-91dd50ab149b (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a70db6c-ae68-49e5-8a4a-b5cd1d4840bd (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e2902d14-16bb-46a9-a45a-4f1f9b0ecf4a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b283d662-9be1-49c7-be03-cb21055314c1 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc768d3e-a7cc-46a2-ae6d-0f5eb2f05406 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb2edaca-6cf2-4100-83f5-8ce142f68e59 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2491e6a9-3415-43b9-b31b-67331f52806a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dca6149-00ca-480e-a887-6861e40803b9 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d83b127-ef13-4b2c-aa30-0f54937dc240 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2ffa81a-86c5-40b9-8fa0-c889801ef479 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b3b6a9f-259c-4736-b88f-f49d1eb64286 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18414c5a-8153-44f7-b27a-90c290af0a23 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b9b15f7-354b-4049-982b-f6f31751a885 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef468722-68cd-440b-afd7-2285029db41f (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37527eca-115e-4582-88cd-bba851ac6069 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c47250c2-bece-46b5-8b3b-b7c97d9005d8 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa32aafd-e3f5-4be6-9413-c7663c1c2cec (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1057be77-00bb-4839-be3d-c8e11ae531a2 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44b6cefc-7638-4437-95e7-8f239f66a9d4 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c64aa79-d087-4568-904c-3a0638b91e69 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf52e242-199b-4206-e053-2a95a90a1eb7 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a093ca6e-9963-4eea-b60d-6e2f148192ec (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b064286b-fedc-be68-e053-2995a90aae52 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cb05412-372e-4b49-92e1-532caa05f38f (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30caadee-3255-e0e3-e063-6294a90a8061 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c12b316f-811c-48b6-a320-d314991aa74f (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b54c195-71ba-2523-e063-6294a90ada73 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec43739e-7154-45a7-add7-bfb8fb779be8 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cfda82e4-8660-447e-a881-b87165a31e9a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf8d4359-a850-97b7-e053-2a95a90aa66a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e4402d4-e0d3-9846-3e81-ed46f34137fe (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:348e810c-e572-f3d2-e063-6394a90a0855 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58388197-82f4-0953-e063-6294a90ac52a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7030109d-5ce0-43f1-a5ed-16a3562acd40 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b5fe0aa-c74f-42f3-a84a-1cb16009aa80 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b0136d72-0869-2da0-e053-2995a90af70a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b996e81b-36ec-4ad7-a7c4-bc6700a06648 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac87e3c7-1e51-4dd1-8b75-dec6536810e3 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f123a2c-3f94-ca2d-e063-6394a90aff68 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fac4466-fbe5-49d2-96e3-e3ac2739bd5b (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:275de35b-5c97-4ff8-a571-42e23c1cd83e (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14c3bc33-201d-492e-9aee-a4d84c813a3d (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae77a5c0-a2ae-770c-e053-2a95a90a6a96 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c611c8c-deed-4904-93f7-f75a2147fbf7 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8eef4f14-e7ef-41be-be57-7993b333e8a9 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e1addcf-6d5b-46c8-812b-558fd847f005 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6bd5021-cf56-4c8a-b5a0-bbc8919740af (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e81341c6-0e25-4860-adda-2d3cebe88d62 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57e5832f-9168-1f24-e063-6294a90aaae6 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:922e9f5c-cc59-4d9e-bf42-a4b900d077ed (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bab9397-b9f3-d309-e053-2991aa0a6612 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4af3894a-8945-4b2d-bdf6-a83bbd415b89 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de0b9579-fb85-e1ce-e053-2a95a90aeecb (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c7bc0d20-526c-48ea-b23a-cea9eb7080ff (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5ecc693-b8fd-4a7a-8040-e56f801c9353 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:178dc379-e2b8-4b47-9f0c-3fc7fb435c36 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f80ab01d-2533-1b4c-e053-6294a90a6e6a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6debb60-d885-230b-e053-6394a90ad73a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47d1e4c5-f669-4aca-9e8c-0d6bb833b859 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a914512b-9a4a-4c53-ab7a-2e2b1ea8a012 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99918613-7936-47dd-8565-9cd6c0cc22e3 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d275175c-691a-4d09-bbb7-50ee819e6727 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e74496f-4dca-4471-be32-c0a14bc62750 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df24efa3-c9a0-4f40-92ce-cc71c708931b (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b3d22dc-df09-4910-8c9b-1204eeedbd68 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7041828f-d4ec-4813-bcac-cb335c6c312a (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e37322b-89d3-4b66-8e1b-c4ad79eed173 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74e2dd24-5c6e-4dde-a2ab-f2d2e61734d8 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d5afeff-3917-43e1-9d12-d70ccab00dcc (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f818ed31-c746-4171-afdf-57a75434e5f1 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26e2d370-f59c-40ae-9c1e-7f8bf1f9fde4 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d8b21832-b74f-4f85-a304-b907c9e01e72 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4deea61e-f3ca-b35d-e063-6294a90a9d41 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b281a5c0-5f3e-4e6f-86ac-ed7794aac64c (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351b41db-622f-a1eb-e063-6294a90a5667 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d6ec3ee-2205-4d78-bc48-d39f371797c1 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46dedf2c-26de-0f46-e054-00144ff88e88 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a57066d7-dc2c-d2d0-b003-d9143fcca1c5 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec337816-4f48-4d04-b91d-60f9f5f634da (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5723eaf9-8659-4730-b792-4e4c33690ccb (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fff7a38-2c4e-d343-e063-6294a90aca3c (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42542f65-84a7-fdab-e063-6394a90a1095 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4149d980-a6cd-c06d-e063-6394a90a47a1 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7e5174a-dd01-6050-e053-2a95a90add3f (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a935846-3c97-4517-bc4e-2377f673285e (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
The serum elimination half-life in subjects with normal renal function is approximately 4 hours.
5 to 6 hours
- Numeric value
- 5
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f406e796-17d9-4465-b8a7-00d966a4ba74 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
Excretion The serum elimination half-life is approximately 5 to 6 hours and the total clearance is around 35 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7049f870-6741-4a67-8033-398c36126a06 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
Excretion The serum elimination half-life is approximately 5 to 6 hours and the total clearance is around 35 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbbbf939-3219-4515-a48e-ca264daa4d07 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
Excretion The serum elimination half-life is approximately 5 to 6 hours and the total clearance is around 35 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42c758be-4d44-018a-e063-6294a90ae041 (opens source in a new tab)
Ciprofloxacin label
Version not recorded · Effective date not recorded
Excretion The serum elimination half-life is approximately 5 to 6 hours and the total clearance is around 35 L/hr.
Projected row 302
- Medicine slug
- cisplatin
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 12
- Source count
- 12
- Agreement rate
- 0.666667
- Recorded readings
36 to 47 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d170f6f-37d7-41ce-aae2-33307a6ef3ae (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76aea034-6d58-4390-a164-36aa09c1f101 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de6302d5-85f0-4116-a709-57826c2c84fe (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00396546-6a80-4b9f-a5f8-c22c1d1bb173 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0219eae9-82b4-b779-e063-6394a90a311e (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bf8d2fb-80c8-401d-8e9b-d58463f5e954 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0372598e-4837-43c6-b56f-63527ac94559 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a32820f7-9ff6-4c13-a96a-4483a943fe82 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
Maximum red blood cell concentrations of platinum are reached within 90 to 150 minutes after a 100 mg/m 2 dose of cisplatin and decline in a biphasic manner with a terminal half-life of 36 to 47 days.
5 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:508496cb-3441-46b3-a4fe-e0d440e6adc6 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
The complexes between albumin and the platinum from cisplatin do not dissociate to a significant extent and are slowly eliminated with a minimum half-life of 5 days or more.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a440f077-46f6-4688-a209-65bce38d1c92 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
The complexes between albumin and the platinum from cisplatin do not dissociate to a significant extent and are slowly eliminated with a minimum half-life of 5 days or more.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a60c5173-6bc0-4c9d-9674-b3f4d68f79ba (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
The complexes between albumin and the platinum from cisplatin do not dissociate to a significant extent and are slowly eliminated with a minimum half-life of 5 days or more.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2b029f5-0d7e-4e7f-accc-b722aec34c68 (opens source in a new tab)
Cisplatin label
Version not recorded · Effective date not recorded
The complexes between albumin and the platinum from cisplatin do not dissociate to a significant extent and are slowly eliminated with a minimum half-life of 5 days or more.
Projected row 303
- Medicine slug
- citalopram
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 91
- Source count
- 90
- Agreement rate
- 1
- Recorded readings
80%
- Numeric value
- 80
- Unit
- %
- Source records
- 90
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 90 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7307df53-d570-4e26-971d-e97522ccce7f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0dfb11d9-f48d-56ee-e063-6294a90ad256 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29408d84-7b00-4cee-969c-8095f8083ff5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2632b547-2e13-447f-ac85-c774e437d6a8 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05421bee-f746-418e-bb9c-ab44a89b567d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c577b306-ee7c-8364-e053-2a95a90abb13 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f815b0c-6da7-cb61-e89c-7de628092d0d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a967468-3869-4c8c-849f-9fc3a8dcc489 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9cc1649-913d-832d-e053-2995a90a5f9a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c8942f8-963a-4007-a147-b77ac629e4d4 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50380ce5-c77f-3ee3-e063-6394a90a17ae (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43785b49-5d1e-4ae9-b2ff-26be910bde7f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b54f10-221f-5eed-e053-2995a90ab47f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c91684c7-fddb-4cf0-9711-b0484c8c7e8b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0867140e-a483-4bf7-8326-4a9730cc9d9d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d2f8f9f-9710-48e0-bc18-105a2af1073b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80af8ae8-c106-4895-bab3-0579b41f1e75 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f35bfd9e-afb6-409d-a804-6073d812609d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0580559a-783a-4a0a-8d81-ee30a29077c5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:625a78b2-4751-4ca5-91b6-7c85fd9f8c2e (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:579836d8-64ed-de2d-e053-2a91aa0a8392 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17af7a8d-ef57-4253-96ed-e457e0062eb5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f37cc307-8b7d-4e5c-8beb-cd8779bc86a7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b244d4eb-8311-4663-8bca-dc08e88e5f5d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8719bd44-36b6-468d-9203-8c53a2645184 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bc0e09e-0f1d-4d52-b8fe-3ef8a2e5ea52 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04766f1d-7a69-49ed-8fd3-1a6305505d47 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1f0c6e8-85eb-4368-8709-9cace32415cb (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b52acd68-fed1-4680-9eaf-b72e7dcba6fb (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6949652-b15b-435b-9097-2219f398ac05 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9809dfe-939e-4f9d-b6dd-f9808fd9f2b1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3237467-286d-480d-8c80-b9a97738edaa (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6730edc-7226-4521-a04a-1bf296b01b8d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ccb3fb-b607-9491-e053-2995a90a39c9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df929b3f-0cda-4a75-96d3-22e6b0edbbc9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e0-19c5-e053-2a95a90a1828 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2500cc9d-a67d-46c5-9a76-99bc63959d67 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7a2cbdd-1bdb-4e59-a3dd-298a189753ae (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc7b3f88-ee55-4e3e-9ed4-fc06aa7620cc (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2640311d-8b88-4513-9c80-a08390b8142a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31a18cdf-b0aa-18f5-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3114274f-d81f-4b1f-8f17-35db9eee2ffe (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a402640-1c9d-4fca-8b5b-e1ac1dd4ca5a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:434094b4-fa3b-385a-e063-6394a90ac638 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8b06b55-f6a2-2438-e053-6394a90a530a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31ddd184-7560-473c-b674-5fa3187c5598 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9059c8f1-8755-492d-aba2-5f5088ce69d3 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f45c818-b324-6ca6-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a8acad8-0ba0-4631-9f6d-f587e7a8558c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b53c14c-224c-49ed-8a00-96f871593ab0 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e5d66f-7902-76ac-e063-6294a90aa526 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9fe40d83-8945-4577-add5-28d52410154e (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b0d184-2a4c-42b0-9a57-7a00fa3e0cd7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e6d0a4-95d9-9c1a-e063-6294a90a9d18 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdc0c228-797a-42dd-8114-aa68c1eb3300 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3541f26-dc8d-6591-e053-2995a90a23d9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9987a273-e6d7-54cd-e053-2a95a90a0aaa (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c133fc77-6c8a-d2b1-e053-2995a90ab5f7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bef27fa1-7876-4ce3-834c-a4855aec66c9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351ca54b-0eb6-4e93-8ab4-82fb18dcc9e1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8e8fde2-8392-4d5b-902b-e2b9dd55a02d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd761647-e16b-45b3-a4bc-364de0ed7015 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549a5b3f-4928-1ae5-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15cb00da-4435-4930-90d0-faadf2739a5c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e22fe468-5d9e-4ec7-a69b-4988e0b8acbd (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a136cc3-d655-4f3c-8710-2603dc008492 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a26772e7-6e4d-489b-bb5e-5bc322ef6dfe (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa9c1440-354f-43a6-9e70-fd7bafcb03c5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4259d9b1-de34-43a4-85a8-41dd214e9177 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75f6db65-e4ed-470a-9e56-12791f22ee9b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fc110ba-87e7-404e-9e00-b680f354c7b0 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08b6d5da-5919-4760-9e16-3b478a14d6d7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3a26d92-b662-4896-82eb-261948042408 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0109f365-bebd-4810-a56f-4451e10245db (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0822069-9672-4d4c-bc1a-8739b0dd045c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df8db06a-ced7-4dd6-83bd-c61d2f68f1b1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7ef6ad2-5f22-4ac7-b57a-f498bcb53be1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544ba802-a536-579a-e054-00144ff88e88 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18330b41-27ad-461b-a0a9-aac94e8ee87f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:825c0c49-5fbf-6d8b-cb8c-94ebf0eda043 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:289c1d5e-902f-47db-85b8-5e1a55ec8684 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc766b76-18c1-42cd-b276-f720f5821c11 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04ac5286-fc2e-4990-a574-ea21131ef731 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c584909b-e7b2-7108-e053-2995a90a2f54 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f77ef23b-3015-d074-e053-6394a90a11e1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27ddea53-f03d-4760-99bb-ec8efa44ff62 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db900453-4777-4142-a236-5d3a6152d0a5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f79f878e-99fb-4757-8abb-931af1fa9e2b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food.
Projected row 304
- Medicine slug
- citalopram
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 91
- Source count
- 90
- Agreement rate
- 0.977778
- Recorded readings
35 hours
- Numeric value
- 35
- Unit
- hours
- Source records
- 88
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 88 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7307df53-d570-4e26-971d-e97522ccce7f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0dfb11d9-f48d-56ee-e063-6294a90ad256 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29408d84-7b00-4cee-969c-8095f8083ff5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2632b547-2e13-447f-ac85-c774e437d6a8 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05421bee-f746-418e-bb9c-ab44a89b567d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c577b306-ee7c-8364-e053-2a95a90abb13 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a967468-3869-4c8c-849f-9fc3a8dcc489 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9cc1649-913d-832d-e053-2995a90a5f9a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c8942f8-963a-4007-a147-b77ac629e4d4 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50380ce5-c77f-3ee3-e063-6394a90a17ae (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43785b49-5d1e-4ae9-b2ff-26be910bde7f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b54f10-221f-5eed-e053-2995a90ab47f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c91684c7-fddb-4cf0-9711-b0484c8c7e8b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0867140e-a483-4bf7-8326-4a9730cc9d9d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d2f8f9f-9710-48e0-bc18-105a2af1073b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f35bfd9e-afb6-409d-a804-6073d812609d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0580559a-783a-4a0a-8d81-ee30a29077c5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:625a78b2-4751-4ca5-91b6-7c85fd9f8c2e (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:579836d8-64ed-de2d-e053-2a91aa0a8392 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17af7a8d-ef57-4253-96ed-e457e0062eb5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f37cc307-8b7d-4e5c-8beb-cd8779bc86a7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b244d4eb-8311-4663-8bca-dc08e88e5f5d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8719bd44-36b6-468d-9203-8c53a2645184 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bc0e09e-0f1d-4d52-b8fe-3ef8a2e5ea52 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04766f1d-7a69-49ed-8fd3-1a6305505d47 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1f0c6e8-85eb-4368-8709-9cace32415cb (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b52acd68-fed1-4680-9eaf-b72e7dcba6fb (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6949652-b15b-435b-9097-2219f398ac05 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9809dfe-939e-4f9d-b6dd-f9808fd9f2b1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3237467-286d-480d-8c80-b9a97738edaa (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6730edc-7226-4521-a04a-1bf296b01b8d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ccb3fb-b607-9491-e053-2995a90a39c9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df929b3f-0cda-4a75-96d3-22e6b0edbbc9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e0-19c5-e053-2a95a90a1828 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2500cc9d-a67d-46c5-9a76-99bc63959d67 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7a2cbdd-1bdb-4e59-a3dd-298a189753ae (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc7b3f88-ee55-4e3e-9ed4-fc06aa7620cc (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2640311d-8b88-4513-9c80-a08390b8142a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31a18cdf-b0aa-18f5-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3114274f-d81f-4b1f-8f17-35db9eee2ffe (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a402640-1c9d-4fca-8b5b-e1ac1dd4ca5a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:434094b4-fa3b-385a-e063-6394a90ac638 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8b06b55-f6a2-2438-e053-6394a90a530a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31ddd184-7560-473c-b674-5fa3187c5598 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9059c8f1-8755-492d-aba2-5f5088ce69d3 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f45c818-b324-6ca6-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a8acad8-0ba0-4631-9f6d-f587e7a8558c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b53c14c-224c-49ed-8a00-96f871593ab0 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e5d66f-7902-76ac-e063-6294a90aa526 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9fe40d83-8945-4577-add5-28d52410154e (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b0d184-2a4c-42b0-9a57-7a00fa3e0cd7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e6d0a4-95d9-9c1a-e063-6294a90a9d18 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdc0c228-797a-42dd-8114-aa68c1eb3300 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3541f26-dc8d-6591-e053-2995a90a23d9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9987a273-e6d7-54cd-e053-2a95a90a0aaa (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c133fc77-6c8a-d2b1-e053-2995a90ab5f7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bef27fa1-7876-4ce3-834c-a4855aec66c9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351ca54b-0eb6-4e93-8ab4-82fb18dcc9e1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8e8fde2-8392-4d5b-902b-e2b9dd55a02d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd761647-e16b-45b3-a4bc-364de0ed7015 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549a5b3f-4928-1ae5-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15cb00da-4435-4930-90d0-faadf2739a5c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e22fe468-5d9e-4ec7-a69b-4988e0b8acbd (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a136cc3-d655-4f3c-8710-2603dc008492 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a26772e7-6e4d-489b-bb5e-5bc322ef6dfe (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa9c1440-354f-43a6-9e70-fd7bafcb03c5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4259d9b1-de34-43a4-85a8-41dd214e9177 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75f6db65-e4ed-470a-9e56-12791f22ee9b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fc110ba-87e7-404e-9e00-b680f354c7b0 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08b6d5da-5919-4760-9e16-3b478a14d6d7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3a26d92-b662-4896-82eb-261948042408 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0109f365-bebd-4810-a56f-4451e10245db (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0822069-9672-4d4c-bc1a-8739b0dd045c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df8db06a-ced7-4dd6-83bd-c61d2f68f1b1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7ef6ad2-5f22-4ac7-b57a-f498bcb53be1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544ba802-a536-579a-e054-00144ff88e88 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18330b41-27ad-461b-a0a9-aac94e8ee87f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:825c0c49-5fbf-6d8b-cb8c-94ebf0eda043 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:289c1d5e-902f-47db-85b8-5e1a55ec8684 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc766b76-18c1-42cd-b276-f720f5821c11 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04ac5286-fc2e-4990-a574-ea21131ef731 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c584909b-e7b2-7108-e053-2995a90a2f54 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f77ef23b-3015-d074-e053-6394a90a11e1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27ddea53-f03d-4760-99bb-ec8efa44ff62 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db900453-4777-4142-a236-5d3a6152d0a5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f79f878e-99fb-4757-8abb-931af1fa9e2b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours.
52.7 hours
- Numeric value
- 52.7
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f815b0c-6da7-cb61-e89c-7de628092d0d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 52.7 hours (30 mg capsule).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80af8ae8-c106-4895-bab3-0579b41f1e75 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 52.7 hours (30 mg capsule).
Projected row 305
- Medicine slug
- citalopram
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 91
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
1 hour
- Numeric value
- 1
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f815b0c-6da7-cb61-e89c-7de628092d0d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
However, median T max of citalopram is delayed by approximately 1 hour (6 vs 5 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80af8ae8-c106-4895-bab3-0579b41f1e75 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
However, median Tmax of citalopram is delayed by approximately 1 hour (6 vs 5 hours).
Projected row 306
- Medicine slug
- citalopram
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 91
- Source count
- 90
- Agreement rate
- 1
- Recorded readings
12 L/kg
- Numeric value
- 12
- Unit
- L/kg
- Source records
- 90
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 90 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7307df53-d570-4e26-971d-e97522ccce7f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0dfb11d9-f48d-56ee-e063-6294a90ad256 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29408d84-7b00-4cee-969c-8095f8083ff5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2632b547-2e13-447f-ac85-c774e437d6a8 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05421bee-f746-418e-bb9c-ab44a89b567d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c577b306-ee7c-8364-e053-2a95a90abb13 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f815b0c-6da7-cb61-e89c-7de628092d0d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a967468-3869-4c8c-849f-9fc3a8dcc489 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9cc1649-913d-832d-e053-2995a90a5f9a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c8942f8-963a-4007-a147-b77ac629e4d4 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50380ce5-c77f-3ee3-e063-6394a90a17ae (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43785b49-5d1e-4ae9-b2ff-26be910bde7f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b54f10-221f-5eed-e053-2995a90ab47f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c91684c7-fddb-4cf0-9711-b0484c8c7e8b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0867140e-a483-4bf7-8326-4a9730cc9d9d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d2f8f9f-9710-48e0-bc18-105a2af1073b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80af8ae8-c106-4895-bab3-0579b41f1e75 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f35bfd9e-afb6-409d-a804-6073d812609d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0580559a-783a-4a0a-8d81-ee30a29077c5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:625a78b2-4751-4ca5-91b6-7c85fd9f8c2e (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:579836d8-64ed-de2d-e053-2a91aa0a8392 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17af7a8d-ef57-4253-96ed-e457e0062eb5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f37cc307-8b7d-4e5c-8beb-cd8779bc86a7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b244d4eb-8311-4663-8bca-dc08e88e5f5d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8719bd44-36b6-468d-9203-8c53a2645184 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bc0e09e-0f1d-4d52-b8fe-3ef8a2e5ea52 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04766f1d-7a69-49ed-8fd3-1a6305505d47 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1f0c6e8-85eb-4368-8709-9cace32415cb (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b52acd68-fed1-4680-9eaf-b72e7dcba6fb (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6949652-b15b-435b-9097-2219f398ac05 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9809dfe-939e-4f9d-b6dd-f9808fd9f2b1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3237467-286d-480d-8c80-b9a97738edaa (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6730edc-7226-4521-a04a-1bf296b01b8d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ccb3fb-b607-9491-e053-2995a90a39c9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df929b3f-0cda-4a75-96d3-22e6b0edbbc9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e0-19c5-e053-2a95a90a1828 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2500cc9d-a67d-46c5-9a76-99bc63959d67 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7a2cbdd-1bdb-4e59-a3dd-298a189753ae (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc7b3f88-ee55-4e3e-9ed4-fc06aa7620cc (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2640311d-8b88-4513-9c80-a08390b8142a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31a18cdf-b0aa-18f5-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3114274f-d81f-4b1f-8f17-35db9eee2ffe (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a402640-1c9d-4fca-8b5b-e1ac1dd4ca5a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:434094b4-fa3b-385a-e063-6394a90ac638 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8b06b55-f6a2-2438-e053-6394a90a530a (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31ddd184-7560-473c-b674-5fa3187c5598 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9059c8f1-8755-492d-aba2-5f5088ce69d3 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f45c818-b324-6ca6-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a8acad8-0ba0-4631-9f6d-f587e7a8558c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b53c14c-224c-49ed-8a00-96f871593ab0 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e5d66f-7902-76ac-e063-6294a90aa526 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9fe40d83-8945-4577-add5-28d52410154e (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b0d184-2a4c-42b0-9a57-7a00fa3e0cd7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e6d0a4-95d9-9c1a-e063-6294a90a9d18 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdc0c228-797a-42dd-8114-aa68c1eb3300 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3541f26-dc8d-6591-e053-2995a90a23d9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9987a273-e6d7-54cd-e053-2a95a90a0aaa (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c133fc77-6c8a-d2b1-e053-2995a90ab5f7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bef27fa1-7876-4ce3-834c-a4855aec66c9 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351ca54b-0eb6-4e93-8ab4-82fb18dcc9e1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8e8fde2-8392-4d5b-902b-e2b9dd55a02d (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd761647-e16b-45b3-a4bc-364de0ed7015 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549a5b3f-4928-1ae5-e054-00144ff8d46c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15cb00da-4435-4930-90d0-faadf2739a5c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e22fe468-5d9e-4ec7-a69b-4988e0b8acbd (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a136cc3-d655-4f3c-8710-2603dc008492 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a26772e7-6e4d-489b-bb5e-5bc322ef6dfe (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa9c1440-354f-43a6-9e70-fd7bafcb03c5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4259d9b1-de34-43a4-85a8-41dd214e9177 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75f6db65-e4ed-470a-9e56-12791f22ee9b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fc110ba-87e7-404e-9e00-b680f354c7b0 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08b6d5da-5919-4760-9e16-3b478a14d6d7 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3a26d92-b662-4896-82eb-261948042408 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0109f365-bebd-4810-a56f-4451e10245db (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0822069-9672-4d4c-bc1a-8739b0dd045c (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df8db06a-ced7-4dd6-83bd-c61d2f68f1b1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7ef6ad2-5f22-4ac7-b57a-f498bcb53be1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544ba802-a536-579a-e054-00144ff88e88 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18330b41-27ad-461b-a0a9-aac94e8ee87f (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:825c0c49-5fbf-6d8b-cb8c-94ebf0eda043 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:289c1d5e-902f-47db-85b8-5e1a55ec8684 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc766b76-18c1-42cd-b276-f720f5821c11 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04ac5286-fc2e-4990-a574-ea21131ef731 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c584909b-e7b2-7108-e053-2995a90a2f54 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f77ef23b-3015-d074-e053-6394a90a11e1 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27ddea53-f03d-4760-99bb-ec8efa44ff62 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db900453-4777-4142-a236-5d3a6152d0a5 (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f79f878e-99fb-4757-8abb-931af1fa9e2b (opens source in a new tab)
Citalopram label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%.
Projected row 307
- Medicine slug
- cladribine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
40%
- Numeric value
- 40
- Unit
- %
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1d650a5-4205-720b-f39b-4213277b6612 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Absorption The bioavailability of cladribine was approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0b363cb-db83-44d6-89d0-1f7176be7459 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Absorption The bioavailability of cladribine was approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c75e30a-a410-40f1-b653-04d532bd9144 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Absorption The bioavailability of cladribine was approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407c52d5-6498-7da5-da35-acc9ca73ced3 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Absorption The bioavailability of cladribine was approximately 40%.
Projected row 308
- Medicine slug
- cladribine
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 0.5
- Recorded readings
1 day
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1d650a5-4205-720b-f39b-4213277b6612 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Elimination Cladribine estimated terminal half-life is approximately 1 day.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0b363cb-db83-44d6-89d0-1f7176be7459 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Elimination Cladribine estimated terminal half-life is approximately 1 day.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c75e30a-a410-40f1-b653-04d532bd9144 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Elimination Cladribine estimated terminal half-life is approximately 1 day.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407c52d5-6498-7da5-da35-acc9ca73ced3 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Elimination Cladribine estimated terminal half-life is approximately 1 day.
5.4 hours
- Numeric value
- 5.4
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71c39b37-33b5-42e1-bf4f-93ff751cc7fe (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
For these patients with normal renal function, the mean terminal half-life was 5.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2592a9b-bca6-4a5a-89c2-855a0634d5fe (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
For these patients with normal renal function, the mean terminal half-life was 5.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f538cba9-001a-4a21-e053-2a95a90a00ec (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
For these patients with normal renal function, the mean terminal half-life was 5.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5736aecc-cc1d-47dd-86c0-5fb2e9d70f61 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
For these patients with normal renal function, the mean terminal half-life was 5.4 hours.
Projected row 309
- Medicine slug
- cladribine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
20%
- Numeric value
- 20
- Unit
- %
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1d650a5-4205-720b-f39b-4213277b6612 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
The plasma protein binding of cladribine is 20% and is independent of concentration, in vitro .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0b363cb-db83-44d6-89d0-1f7176be7459 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
The plasma protein binding of cladribine is 20% and is independent of concentration, in vitro .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c75e30a-a410-40f1-b653-04d532bd9144 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
The plasma protein binding of cladribine is 20% and is independent of concentration, in vitro.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407c52d5-6498-7da5-da35-acc9ca73ced3 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
The plasma protein binding of cladribine is 20% and is independent of concentration, in vitro .
Projected row 310
- Medicine slug
- cladribine
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
0.5 h
- Numeric value
- 0.5
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1d650a5-4205-720b-f39b-4213277b6612 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Following fasted administration of cladribine, the median time to maximum concentration (T max ) was 0.5 h (range 0.5 to 1.5 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0b363cb-db83-44d6-89d0-1f7176be7459 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Following fasted administration of cladribine, the median time to maximum concentration (T max ) was 0.5 h (range 0.5 to 1.5 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c75e30a-a410-40f1-b653-04d532bd9144 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Following fasted administration of cladribine, the median time to maximum concentration (T max ) was 0.5 h (range 0.5 to 1.5 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407c52d5-6498-7da5-da35-acc9ca73ced3 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Following fasted administration of cladribine, the median time to maximum concentration (T max ) was 0.5 h (range 0.5 to 1.5 hours).
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=300Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.